Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.
A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.
Dr Aysha Akhtar joins Ethics Talk to discuss her article, coauthored with Mikalah Singer, “With What Should We Replace Nonhuman Animals in Biomedical Research Protocols?”
Erin Sharoni joins Ethics Talk to discuss her article: “Which Concepts Are Key to Transitioning From Nonhuman Animal Models to Engineered Microphysiological Systems in Biomedical Research?”
Dr David DeGrazia joins Ethics Talk to discuss why the “3 R’s” of nonhuman animal research might not be sufficient to promote good science, ethics, and nonhuman animal welfare.
Professor Richard L. Cupp Jr joins Ethics Talk to discuss his article: “How Might Corporations’ and Nonhuman Animals’ Personhood Compare Under the Fifth and Fourteenth Amendments?”
Laurie Sellars joins Ethics Talk to discuss her article, coauthored with Dr Jeff Sebo: “How Should Treatment of Animals Beyond the Lab Factor Into Institutional Review?”